level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 50 /hr
Hire Dr. Hanna B.
Israel
USD 50 /hr

Biology, Biotech and Pharmaceutical Compliance , Regulatory affairs, Project Manager and sceintific writer

Profile Summary
Subject Matter Expertise
Services
Writing Medical Writing, Technical Writing
Work Experience

Evaluator

Ministry of Innovation, Science and Technology

- Present

MTS Senior Director

Biotechnology general - Ferring

October 2010 - March 2023

Projects management in Manufacturing

Biotechnology Generfal- Ferring

February 2008 - January 2009

Kamada R&D VP and Process Development activities

Kamada

January 2005 - January 2008

RA Manager

Omrix - Johonson &Johnson

July 2004 - August 2005

Reseacher

Interpharm Ltd.

October 1998 - August 2004

Process Development Project Manager

Insight

September 1997 - August 1998

Scientific researchers

Biotechnology General

June 1982 - August 1997

Education

PhD

Hebrew University, Jerusalem

July 1990 - September 1995

PhD (Virology)

Hebrew University of Jerusalem

1990 - 1995

MSc

Tel Aviv University

September 1980 - October 1982

Certifications
  • AI annotatioin

    I merit

    May 2026 - Present

  • Certified Regulatory Compliance Manager

    Pharma Job

    February 2002 - Present

  • Certified Pharmaceutical GMP Professional

    Biotechnology General

    October 1998 - Present

Publications
JOURNAL ARTICLE
Hanna Ben-Artzi, Yuval Ramot, Noam Kronfeld, Yakir Ophir, Nati Ezov, Sheli Friedman, Markku Saloheimo, Marika Vitikainen, Avi Avigdor, Ronen Tchelet, et al. (2022). Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 <i>Thermothelomyces Heterothallica</i> Protein Expression Platform . Toxicologic Pathology.
Hanna Ben-Artzi, Jenny Shemesh, Elisha Zeelon, Boaz Amit, Lawrence Kleiman, Marian Gorecki, Amos Panet (1996). Molecular Analysis of the Second Template Switch During Reverse Transcription of the HIV RNA Template . Biochemistry.
Hanna Ben Artzi, Jenny Shemesh, E. Zeelon, Boaz Amit, Lawrance Kleiman, Marian Gorecki, Amos Panet (1996). Ribonuclease H Activity during Initiation of Reverse Transcription Using tRNAlys/RNA Primer/Template of Human Immunodeficiency Virus . Archives of Biochemistry and Biophysics.
H. Ben-Artzi, E. Zeelon, B. Amit, A. Wortzel, M. Gorecki, A. Panet (1993). RNase H activity of reverse transcriptases on substrates derived from the 5' end of retroviral genome . Journal of Biological Chemistry.
Meir Fischer, Ruth Lifshitz, Tova Katz, Ilana Liefer, Hana Ben-Artzi, Marian Gorecki, Amos Panet, Elisha Zeelon (1992). Comparative analysis of native and cysteine-deficient HIV-1 reverse transcriptase . Protein Expression and Purification.
Hanna Ben-artzi (1992). ,.netToxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform. Toxicologic Pathology. Volume 50, Issue 3.
Hana Ben-Artzi, Elisha Zeelon, Stuart F.J. Le-Grice, Marian Gorecki, Amos Panet (1992). Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases . Nucleic Acids Research.
T Vogel, K H Weisgraber, M I Zeevi, H Ben-Artzi, A Z Levanon, S C Rall, T L Innerarity, D Y Hui, J M Taylor, D Kanner (1985). Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E . Proceedings of the National Academy of Sciences.